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Vacuolization of mucolipidosis type II mouse
exocrine gland cells represents accumulation
of autolysosomes
Marielle Boonena,*, Eline van Meelb,*, Viola Oorschotb, Judith Klumpermanb, and Stuart Kornfelda
a

Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110; bDepartment of
Cell Biology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands

ABSTRACT We previously reported that mice deficient in UDP-GlcNAc:lysosomal enzyme
GlcNAc-1-phosphotransferase (mucolipidosis type II or Gnptab −/− mice), the enzyme that
initiates the addition of the mannose 6-phosphate lysosomal sorting signal on acid hydrolases,
exhibited extensive vacuolization of their exocrine gland cells, while the liver, brain, and muscle appeared grossly unaffected. Similar pathological findings were observed in several exocrine glands of patients with mucolipidosis II. To understand the basis for this cell type–specific abnormality, we analyzed these tissues in Gnptab −/− mice using a combined immunoelectron
microscopy and biochemical approach. We demonstrate that the vacuoles in the exocrine
glands are enlarged autolysosomes containing undigested cytoplasmic material that accumulate secondary to deficient lysosomal function. Surprisingly, the acid hydrolase levels in these
tissues ranged from normal to modestly decreased, in contrast to skin fibroblasts, which accumulate enlarged lysosomes and/or autolysosomes also but exhibit very low levels of acid
hydrolases. We propose that the lysosomal defect in the exocrine cells is caused by the combination of increased secretion of the acid hydrolases via the constitutive pathway along with
their entrapment in secretory granules. Taken together, our results provide new insights into
the mechanisms of the tissue-specific abnormalities seen in mucolipidosis type II.
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INTRODUCTION
Mucolipidosis type II (MLII, inclusion-cell disease or I-cell disease) is
an autosomal recessive disorder due to deficiency of UDPGlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase (GlcNAc1-phosphotransferase), the first enzyme involved in the synthesis of
the mannose 6-phosphate (Man-6-P) signal, which allows the spe-
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cific targeting of lysosomal acid hydrolases from the trans-Golgi network (TGN) to lysosomes (Kornfeld and Sly, 2000; Pohl et al., 2009;
Cathey et al., 2010; Kollmann et al., 2010). The fibroblasts of MLII
patients have been shown to hypersecrete most of their newly synthesized acid hydrolases via the constitutive secretory pathway,
thereby accounting for the deficiency of acid hydrolases in these
cells and, at least partially, for the high level of these same hydrolases in the extracellular fluids of the patients (Leroy and Demars,
1967; Lightbody et al., 1971; Tondeur et al., 1971; Wiesmann et al.,
1971a, 1971b; Hickman and Neufeld, 1972; Leroy et al., 1972; Aula
et al., 1975; Martin et al., 1975). At the morphological level, the
most striking alterations have been found in these fibroblasts and
other cell types of mesenchymal origin, which develop a lysosomal
storage phenotype characterized by the accumulation of phasedense inclusions that gave rise to the term “inclusion-cell disease”
(Leroy and DeMars, 1967; Kenyon and Sensenbrenner, 1971; Aula
et al., 1975; Martin et al., 1975; Nagashima et al., 1977). By contrast,
other cell types exhibit few, if any, morphological alterations, including most cells of the hepatic parenchyma, CNS, and muscle (Kenyon
et al., 1973; Martin et al., 1975, 1984; Nagashima et al., 1977). Interestingly, a more recent report described striking vacuolization at a
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novel site: the serous secretory cells of the pancreas and salivary
glands of several infants with MLII (Elleder and Martin, 1998). In that
study, the origin of the vacuoles was not explained and the acid
hydrolase content of these tissues was not determined. During the
course of studying mice mutant in the gene Gnptab, which encodes
the α/β catalytic subunits of GlcNAc-1-phosphotransferase (MLII
mouse model), we observed similar vacuolization in the exocrine
secretory cell types (Gelfman et al., 2007; Vogel et al., 2009). This
finding provided the opportunity to investigate the nature and
cause of this pathological alteration.
In this article, we demonstrate that the vacuolization of the acinar
cells of the pancreatic and salivary glands of Gnptab −/− mice (or
MLII mice) seen by light microscopy represents the accumulation of
numerous, large autolysosomes, involved in crino-, micro-, and macroautophagy. Interestingly, enzymatic assays revealed that these
glands have only a modest decrease in acid hydrolase content, in
contrast to the major deficiency exhibited by the skin fibroblasts
derived from the mutant mice, in which we also detected an accumulation of enlarged lysosomes and/or autolysosomes by electron
microscopy. On the basis of our findings and the current understanding of the special role of the Man-6-P recognition system in
secretory cells, we propose that the lack of Man-6-P signals on the
acid hydrolases results in their entrapment within exocrine gland
secretory granules as well as increased secretion and, consequently,
in lysosomal dysfunction. These results suggest that hypersecretion
of acid hydrolases via the constitutive secretory pathway may not be
the only cause for the development of lysosomal insufficiency in
mucolipidosis II mice and patients.

RESULTS
Vacuolization of the acinar cells of the salivary glands
and pancreas of Gnptab −/− mice represents accumulation
of autolysosomes
The acini of the exocrine salivary glands, which consist of mucousand serous-type secretory cells, exhibited extensive vacuolization in
Gnptab −/− mice when examined by light microscopy (Gelfman
et al., 2007; Vogel et al., 2009). To gain insight into the underlying
pathology, we analyzed the submandibular salivary gland of these
mice by electron microscopy (EM). Both mucous- and serous-type
secretory cells were readily observed in the wild-type mice
(Figure 1A). By contrast, the overall architecture of the submandibular salivary gland of the Gnptab −/− mice was so grossly disrupted
that it greatly hampered the identification of the serous cells in the
EM sections (Figure 1B). The mucous-type secretory cells, however,
could be recognized by their characteristic electron lucent secretory
granules (average diameter size ∼800 nm). These cells were packed
with large (up to ∼4 μm in diameter) membrane-bound vacuoles that
contained heterogeneous material (Figure 1B arrowheads, higher
magnification in Figure 1C), which accounted for the extensive vacuolization observed by light microscopy. Detailed morphological
analysis of these vacuoles in Gnptab −/− mucous cells showed that
they often contained material reminiscent of undigested cytoplasmic organelles, particularly mitochondria (Figure 1D), suggesting a
defect in the autophagic pathway.
Macroautophagy (hereafter referred to as autophagy), which is
the most prevalent type of autophagy in most tissues, starts with the
sequestration of cargo destined for degradation in a large doublemembrane vesicle, the autophagosome. The fusion of the autophagosome with a lysosome gives rise to an autolysosome, where degradation of the cargo takes place (Cao and Klionsky, 2007). Recent
studies of the lysosomal storage disorders “multiple sulfatase deficiency” and “mucopolysaccharidosis type IIIA” in mice reported the
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accumulation of autophagosomes in mouse embryonic fibroblasts
and macrophages, resulting from defective autophagosome–lysosome fusion (Settembre et al., 2008). We therefore asked whether a
similar block in autophagy might be occurring in the Gnptab −/−
submandibular gland. The large vacuoles filled with undegraded
cytoplasmic material that accumulate in the Gnptab −/− mucous
cells were surrounded by a single membrane (Figure 1, C and D)
and, as shown in Figure 1D, LAMP-2 was readily detected by cryoimmunogold EM in their limiting membrane. These observations
indicate that they represent autolysosomes formed by fusion of autophagic compartments with lysosomes. In this regard, these results
differ from the accumulation of autophagosomes reported in the
other lysosomal storage disorders.
Interestingly, we observed numerous fusion profiles of mucous
granules with the autolysosomes, consistent with ongoing
crinophagy, an autophagic process by which secretory granules directly fuse with lysosomes or autolysosomes (Figure 1, E and F, arrows) (Smith and Farquhar, 1966). We also found mucous secretory
granules that were being engulfed by autolysosomes, a process described as microautophagy (Figure 1, E and G, arrowhead) (Cuervo,
2004).
In addition to the salivary gland, the exocrine pancreas of the
Gnptab −/− mice also exhibited a clear vacuolization under the light
microscope (Gelfman et al., 2007; Vogel et al., 2009). EM analysis
revealed that the acinar cells of this organ, which are serous-type
secretory cells, were similarly affected by the loss of the Man-6-P
targeting pathway. In the wild-type pancreas, LAMP-2 localized to
normal sized lysosomes with a diameter of ∼300–600 nm (Figure 2A).
By contrast, the Gnptab −/− serous cells exhibited an accumulation
of large LAMP-2 positive compartments, which had an approximate
diameter of 500 nm to 2 μm and were filled with undegraded cytoplasmic material (Figure 2, B-D). Mitochondrial remnants were regularly observed in the lumen of these compartments (Figure 2B) and
undigested secretory granules were occasionally detected (Figure
2, C and D). Therefore, as in the salivary gland, these compartments
could be identified as autolysosomes on the basis of their content
and membrane protein composition. LAMP-2 negative autophagosomes were also occasionally observed (unpublished data). Consistent with the accumulation of LAMP-2 positive autolysosomes, the
level of LAMP-2 as determined by Western blotting was markedly
increased in the Gnptab −/− pancreas, as well as in the mutant parotid, sublingual, and submandibular salivary glands (Figure 3A). In
contrast, the brain, liver, and muscle exhibited normal levels of
LAMP-2 in the mutant mouse compared with wild-type (Figure 3A).
Of note, the secretory granules in the Gnptab −/− pancreatic acinar
cells appeared similar to those of the wild-type cells in shape and
density (Figure 2, E and F) but were smaller in size (∼27% smaller
compared with wild type).

Gnptab −/− exocrine glands lack signs of a strong induction
of macroautophagy
One mechanism that could lead to the accumulation of autolysosomes in the salivary and pancreatic glands of the Gnptab −/−
mice would be an enhanced activation of the autophagy process
that might overwhelm the lysosomal degradative capacity. To address this possibility, we determined the levels of Beclin-1 and the
activity of the serine/threonine kinase mTOR (target of rapamycin)
in the salivary glands and pancreas of the Gnptab −/− and wildtype mice. Beclin-1 and mTOR are key regulators in the process of
macroautophagy (Pattingre et al., 2008). Increased levels of Beclin-1, which is part of a PI(3)-kinase complex, activate and up-regulate the process of autophagy through its interaction with hVps34
Molecular Biology of the Cell

Figure 1: Autolysosomes accumulate in the submandibular salivary gland of Gnptab −/− mice. (A) Electron
micrograph showing a low-magnification overview of a wild-type (WT) mouse submandibular salivary gland acinus,
composed of mucous and serous cells. (B) Overview of a Gnptab −/− submandibular salivary gland acinus. The overall
architecture is disrupted by the massive accumulation of large vacuoles with diameter sizes up to ∼4 μm (arrowheads).
Mucous-type secretory cells are recognized by the presence of the electron lucent secretory granules (average diameter
size ∼800 nm). (C) Higher magnification of a vacuole from (B), which is surrounded by a single membrane and contains
undegraded material. Area of magnification is indicated by the box in (B). (D, E) Further characterization of the vacuoles
that accumulate in the Gnptab −/− submandibular salivary gland shows the presence of the lysosomal membrane
protein LAMP-2 in their limiting membrane by immunogold labeling (D, 10-nm gold particles), mitochondria inside their
lumen (D), fusion with (E, arrows) and engulfment (E, arrowhead) of mucous secretory granules (crinophagy and
microautophagy events, respectively). Taken together, these observations define these vacuoles as autolysosomes.
Higher magnifications of the (F) crinophagy and (G) microautophagy events shown in (E). Areas of magnification are
indicated by the boxes in (E). AL, autolysosome; M, mitochondrion; Mu, mucous cell; N, nucleus; S, serous cell; SG,
secretory granule.
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Figure 2: The acinar cells of Gnptab −/− mouse pancreas accumulate autolysosomes. (A–C) Ultrathin cryosections of
wild-type and Gnptab −/− mouse exocrine pancreatic cells, immunogold labeled (10-nm gold particles) for LAMP-2.
(A) Typical example of a LAMP-2 positive lysosome in wild-type (WT) cells. (B, C) Gnptab −/− pancreatic acinar cells
accumulate numerous large LAMP-2 positive organelles that contain cytoplasmic material (asterisks), including
(B) mitochondrial remnants and (C) secretory granules, which defines them as autolysosomes. The arrowheads in
(C) show LAMP-2 labeling on the limiting membrane of the autolysosome, indicating that the secretory granule is
enclosed within the autolysosome. (D) Another example of an autolysosome in Gnptab −/− pancreatic acinar cells that
contains a secretory granule. The arrowheads indicate the membrane of the secretory granule, showing that the granule
is inside the lumen of the autolysosome. (E, F) Immunogold labeling for amylase in (E) wild-type and (F) Gnptab
−/− pancreas showing numerous secretory granules that appear similar in shape and density, albeit smaller in size in the
Gnptab −/− cells. AL, autolysosome; G, Golgi apparatus; ISG, immature secretory granule; L, lysosome;
M, mitochondrion; PM, plasma membrane; SG, secretory granule.

(Cao and Klionsky, 2007). The mTOR (kinase complex 1) is a central
element in several sensing-signaling pathways that regulate cellular processes such as cell growth, nutrient import, protein synthesis, and autophagy (Pattingre et al., 2008). It has been reported
that, under various stress conditions, the inhibition of mTOR results
in up-regulation of autophagy (Pattingre et al., 2008; Jung et al.,
2010). We analyzed the activity of mTOR in the Gnptab −/− tissues
by measuring the phosphorylation level of one of its downstream
targets, the ribosomal kinase S6K (p70S6K). Our analysis showed
that the level of Beclin-1 was slightly elevated in the Gnptab −/−
exocrine glands (with the exception of the sublingual gland),
whereas the phosphorylation of p70S6K was highly increased in
1138 | M. Boonen et al.

these same tissues compared with wild-type animals (Figure 4A).
These data indicate that, while the process of autophagy may be
stimulated via the Beclin-1 pathway in the mutant cells, at the same
time it is being inhibited by the activation of the mTOR pathway.
Taken together, these observations suggest that macroautophagy
is not strongly enhanced in these tissues. In accordance with this
observation, evaluation of the occurrence of autophagosomes in
EM sections of Gnptab −/− and wild-type pancreas did not reveal
a significant increase in the number of these organelles in the mutant mice compared with wild-type (1.1 ± 0.2 autophagosomes per
Gnptab −/− cell profile compared with 0.6 ± 0.1 for wild-type,
p = 0.11) (Figure 4B). In contrast, the marked increase in the
Molecular Biology of the Cell

granules with these compartments (microautophagy and crinophagy,
respectively) were often observed, suggesting that these processes
may be stimulated even though the degree of macroautophagy
appears not to be (Figure 1, E–G).
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Figure 3: Steady-state levels of autophagy markers and lysosomal
proteins in different tissues of wild-type and Gnptab −/− mice. (A) The
levels of LAMP-2, LC3-II, and ubiquitinated proteins are greatly
increased in the salivary and pancreatic glands of Gnptab −/− mice.
Western blotting of the autophagy marker LC3 reveals that the level
of the phosphatidylethanolamine-conjugated form of the protein,
LC3-II, is highly increased in the parotid, sublingual, and
submandibular salivary glands, as well as in the pancreas of the
Gnptab −/− mice. An increase in the level of LAMP-2 is detected in
the same organs, whereas the levels of both LC3-II and LAMP-2 are
unchanged in the brain, liver, and muscle of the Gnptab −/− animals
compared with wild-type levels. The immunoblot detection of
ubiquitin shows that the levels of ubiquitinated proteins are modestly
to strongly increased in the Gnptab −/− mouse salivary and
pancreatic glands, while barely changed, if at all, in the brain and
muscle of these mice compared with wild-type levels. A slight
elevation of the level of ubiquitinated proteins is detected in the liver
of the Gnptab −/− mice. The substrate of chaperone-mediated
autophagy, GAPDH, is slightly increased in the exocrine secretory
glands. (B) Cathepsin D levels as determined by Western blotting are
similar in the Gnptab −/− submandibular salivary gland and slightly
increased in the Gnptab −/− pancreas compared with wild-type levels.
The mature enzyme is detected as a 39-kDa band, and partial
processing to the heavy and light chain occurs in these tissues as
shown by the presence of the 27-kDa band representing the heavy
chain. Note that cathepsin D runs slightly slower in the Gnptab −/−
tissues, which is due to differential processing of its N-linked glycans.

number of autolysosomes in Gnptab −/− acinar cells (26.2 ± 3.1
per cell profile vs. 1.5 ± 0.6 for the wild-type cells), as well as the
decrease in the number of lysosomes (0.1 ± 0.1 in Gnptab −/− vs.
2.7 ± 0.5 in wild-type), attained statistical significance (p < 0.01).
It should be noted, however, that in the Gnptab −/− mucoustype secretory cells of the submandibular gland, engulfment of secretory granules by autolysosomes and direct fusion of secretory
Volume 22 April 15, 2011

The acinar cells of Gnptab −/− mice exhibit decreased
lysosomal degradative capacity
Our EM analysis showed that the acinar cells of the mutant mice
submandibular and pancreatic glands accumulate autolysosomes
that are filled with autophagic substrates, that is, secretory granule
and mitochondrial remnants. By Western blot, we determined that
this defect was accompanied by an increase in the level of LC3-II,
which was also detected in the parotid and sublingual salivary
glands of the mutant mice (Figure 3A). LC3-II is the phosphatidylethanolamine conjugated form of LC3-I that is formed upon recruitment of LC3-I from the cytosol onto the autophagosomal membrane during the process of autophagosome formation. After
autophagosome closure, LC3-II on the surface of the autophagosome is released back into the cytosol, whereas the luminal pool of
LC3-II is normally degraded after fusion of the autophagosomes
with the lysosomes (Pattingre et al., 2008). Because no obvious induction of macroautophagy was detected in the mutant glands, and
because our EM analysis showed that the fusion of autophagosomes with lysosomes is not blocked in those tissues, the increase
in the level of LC3-II strongly suggests a delay in its degradation
within autolysosomes.
We also observed a striking increase in ubiquitinated proteins in
the Gnptab −/− secretory glands compared with wild-type, especially in the mutant submandibular salivary gland and pancreas (Figure 3A). It was recently proposed that impaired progression of autophagy delays the delivery in ubiquitinated substrates to the
proteasome (Korolchuk et al., 2009), which could, at least in part,
account for the increase of ubiquitinated proteins detected in the
Gnptab −/− glands. In addition, because autophagy is a bulk degradation process, ubiquitinated proteins present in the cytosolic
portions that are engulfed within forming autophagosomes would
be expected to accumulate secondary to a defect of autolysosomal
degradation. Finally, the Gnptab −/− glands displayed a slight increase in GAPDH, which is a substrate of chaperone-mediated autophagy, a process by which cytosolic proteins are directly translocated to the lysosomal lumen for degradation (Aniento et al., 1993)
(Figure 3A). These findings are all consistent with a defect in the
degradative function of the lysosomes.
To determine whether this decrease in lysosomal degradative capacity might be accounted for by a reduction in the acid hydrolase
content in lysosomes, we measured the activity of a number of lysosomal glycosidases (Table 1). All of these glycosidases are known to
acquire the Man-6-P recognition marker (Sleat et al., 2008), with the
exception of β-glucocerebrosidase, which is targeted to the lysosomes by a Man-6-P–independent mechanism (Reczek et al., 2007).
The activities of α-mannosidase, β-galactosidase, β-mannosidase,
and β-glucuronidase were modestly decreased in the pancreas of the
Gnptab −/− mice (39–61% of wild-type levels) and in the submandibular salivary gland (28–89% of wild-type levels). The activity of
α-galactosidase, however, was slightly elevated in both of these tissues of the mutant mice, while the activity of β-hexosaminidase was
greatly increased in the pancreas (13.2-fold) but modestly decreased
in the submandibular salivary gland. β-Hexosaminidase, in contrast to
the other five glycosidases, has been shown to be associated with the
lysosomal membrane (Yadao et al., 1997; Magini et al., 2008), as is
β-glucocerebrosidase, whose activity was increased in both −/− pancreas and salivary gland (2.7- and 2.1-fold, respectively). However, it
MLII mice accumulate autolysosomes
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Ratio
–/–/WT

–/–
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WT

–/–

Ratio
–/–/WT

Brain

α-Mannosidase

6.8 ± 2.0

3.9 ± 0.9*
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5.0 ± 0.6

7.6 ± 1.3*

1.52

β-Galactosidase
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4.0 ± 0.7

6.0 ± 4.6

1.50
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2.2 ± 1.2*

0.57

β-Glucuronidase

19.4 ± 2.4
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Activities are expressed as nmol of methylumbellyferone released per mg protein per hour.
The values are the average ± SD, with n ≥ 6.
*p < 0.01; ND, not determined.
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Table 1: Activity of acid hydrolases in wild-type (WT) and Gnptab –/– tissues and fibroblasts.a
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Figure 4: Analysis of mTOR activity and Beclin-1 levels in wild-type and Gnptab −/− exocrine
tissues. (A) Western blot showing the levels of Beclin-1 and the mTOR target p70S6K (total and
phosphorylated) in wild-type and Gnptab −/− salivary glands (parotid, sublingual, and
submandibular) and pancreas. Equal amounts of protein were loaded, as reflected by the equal
levels of total p70S6K in each lane. Note the very slight increase in the level of Beclin-1, and the
more pronounced increase in the amount of phosphorylated p70S6K, in the −/− tissues
compared with wild-type levels. (B) Graph representing the quantification of the number of
autolysosomes, autophagosomes, and lysosomes present detected per cell profile by EM in the
pancreas of wild-type and Gnptab −/− mice. The number of autolysosomes and lysosomes are
significantly increased and decreased in Gnptab −/− (p < 0.01), respectively, whereas the
number of autophagosomes is not changed.
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is not clear at this point that the membrane
association of β-hexosaminidase is related to
the increased activity in the −/− pancreas,
nor is it clear how this association would affect the targeting of this hydrolase.
We next determined the steady-state
level of the protease cathepsin D in wildtype and Gnptab −/− submandibular salivary gland and pancreas by Western blotting. As shown in Figure 3B, the level of
cathepsin D was similar to wild-type or even
slightly increased in these Gnptab −/− tissues. In both tissues the major band was
detected at ∼39 kDa, which corresponds to
the mature form of the enzyme. Some of the
mature cathepsin D was processed into the
heavy and light chains, as shown by the
presence of the ∼27-kDa heavy chain band.
Cathepsin D had a slightly higher molecular
weight in Gnptab −/− tissues, reflecting the
differential processing of its N-linked
glycans, which occurs in the absence of
Molecular Biology of the Cell

The autolysosomes of the Gnptab −/−
acinar cells contained low levels of cathepsin D labeling (Figure 5, E and F), consistent
with dilution of the protease following fusion of the lysosomes with the autophagosomes. Because the total volume of autolysosomes in the Gnptab −/− acinar cells is so
much larger than that of the lysosomes, a
significant proportion of the total intracellular level of cathepsin D likely localizes to
these compartments.

Loss of the Man-6-P signal does not
affect tissues equally
Interestingly, in contrast to the exocrine
glands of the Gnptab −/− mice, the liver,
brain, and muscle of these mice contained
normal levels of LAMP-2 and LC3-II (Figure
3A) and did not exhibit generalized vacuolization when examined by light or electron
microscopy. In addition, the level of ubiquitinated proteins and GAPDH was unchanged
in the muscle and brain of the Gnptab −/−
mice compared with wild-type levels. Thus,
at this level of analysis, the loss of the Man6-P recognition system does not appear to
impair the functioning of the autophagy or
lysosomal system in these tissues. The liver
of the mutant mice did exhibit a modest increase in the level of ubiquitinated proteins,
although there was no accumulation of autolysosomes detected in this organ by EM
(Supplemental Figure 1, A–D), and the levels of LC3-II and LAMP-2 were normal.
Direct enzyme assays revealed that the
levels of the acid hydrolases in the brain
and muscle of the Gnptab −/− mice were
Figure 5: Lysosomes of Gnptab −/− pancreatic acinar cells contain reduced levels of cathepsin
normal or even somewhat elevated comD. (A–F) Ultrathin cryosections of (A, B) wild-type and (C–F) Gnptab −/− pancreatic acinar cells
pared with wild-type levels (1.0–1.8-fold)
immunogold labeled for cathepsin D (10-nm gold particles) and LAMP-1 (15 nm). (C, D) The
with the exception of β-galactosidase and
endolysosomes in Gnptab −/− cells contain less cathepsin D compared with (A, B) wild-type
α-galactosidase, whose activities were
cells. (E, F) Autolysosomes in Gnptab −/− pancreatic acinar cells contain low levels of cathepsin
modestly decreased in the −/− brain by 39
D. AL, autolysosome; L, lysosome; LE, late endosome.
and 29%, respectively (Table 1). The liver
phosphorylation of high-mannose–type sugar chains (Gelfman
of the Gnptab −/− mice exhibited an increase in the activity of all
et al., 2007).
the acid hydrolases measured (1.2–3.1-fold). To determine whether
The intracellular localization of cathepsin D in wild-type and
the acid hydrolases were actually in lysosomes, membrane fractions
Gnptab −/− pancreatic acinar cells was then evaluated by immunoof brain and liver (from wild-type or Gnptab −/− mice) were fracEM. Cathepsin D was readily detected in LAMP-1 positive late entionated on 18% self-forming Percoll density gradients as described
dosomes and lysosomes of cells of both types of mice (Figure 5,
previously (Boonen et al., 2009), a technique that allows concenA–D) and in the autolysosomes of the Gnptab −/− acinar cells (Figtration of lysosomes in the densest fraction of the gradient (Figure 5, E and F). By quantification, the endolysosomes of wild-type
ure 6), while the other organelles remain in the lighter fractions
cells contained 11.3 ± 11.6 gold particles per compartment, whereas
(Supplemental Figure 2). The analysis of the distribution of three
lower values (5.3 ± 4.6 gold particles per compartment) were meadifferent acid hydrolases (β-hexosaminidase, α-galactosidase, and
sured in the Gnptab −/− endolysosomes (p = 0.012). Moreover, we
α-mannosidase) revealed that a similar proportion of acid hydroobserved that the average surface area of the individual late-endolases localized to the dense-lysosome fraction in both organs, indisomal and lysosomal compartments in Gnptab −/− cells was 1.4×
cating that the lysosomes of Gnptab −/− brain and liver receive
larger compared with wild-type levels. Consequently, the density of
normal levels of acid hydrolases (Figure 6).
cathepsin D labeling in the late endosomes and lysosomes of the
Gnptab −/− pancreatic acinar cells was reduced to 37% of the labelSkin fibroblasts of Gnptab −/− mice accumulate lysosomes
ing density in wild-type cells (53.3 ± 50.1 vs. 144.5 ± 103.8 gold
and/or autolysosomes deficient in acid hydrolases
particles per μm2, respectively, p = 7.35 × 10−5), indicating decreased
Because the presence of “inclusions” in fibroblasts of mucolipilysosomal targeting of cathepsin D in these cells.
dosis type II patients is the hallmark of the disorder (also called
Volume 22 April 15, 2011
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(Aula et al., 1975). Therefore we isolated
skin fibroblasts from the Gnptab −/− mice
and examined them by immuno-EM.
Figure 7A shows strong labeling of the
lysosomal protease cathepsin D in skin fibroblasts of wild-type mice. Lysosomes
with a diameter of 400–600 nm were de
tected, containing lamellar material as
well as small internal membrane vesicles.
By contrast, the fibroblasts derived from
the Gnptab −/− mice had increased numbers of lysosomes that contained very low
levels of cathepsin D (Figure 7B) but were
positive for the lysosomal membrane protein LAMP-2 (Figure 7, C and D). This deficiency of cathepsin D reflects the known
hypersecretion of this protease by this cell
type (Lee et al., 2007). The lysosomes
were enlarged (up to ∼1.5 μm in diameter),
filled with dense amorphous material, and
occupied much of the cytoplasm (Figure
7C). Mitochondrial remnants were occasionally detected within these compartments, indicating that they had received
material via the autophagic pathway and
had become autolysosomes (Figure 7D).
The difference in size and composition of
these enlarged lysosomes and autolysosomes (∼1.5 μm, mainly amorphous content) compared with their counterparts in
the exocrine tissues (up to 4 μm with numerous organelle remnants) might explain
why the latter gave rise to vacuolization
that is readily detectable in paraffin sections while the other did not.
Measurements of the activity of five lysosomal hydrolases revealed extremely low
levels in the Gnptab −/− fibroblasts (8–25%
of wild-type levels), whereas the activity of
β-glucocerebrosidase was increased fourfold over wild-type levels (Table 1). The
Gnptab −/− fibroblasts also showed inFigure 6: The subcellular distribution of acid hydrolases in the brain and liver of wild-type and
creased levels of LAMP-2 and LC3-II, as
Gnptab −/− mice is similar in a self-forming Percoll density gradient. Wild-type or Gnptab −/−
well as a slight increase in ubiquitinated
liver and brain were homogenized in isotonic sucrose with a Potter-Elvehjem homogenizer and
proteins compared with wild-type fibrocentrifuged at 1000 g to prepare a postnuclear supernatant (PNS). The PNS was subjected to
blasts (Figure 8, A and B). No difference in
centrifugation at 35,000 rpm in a 50Ti rotor for 40 min at 4ºC to obtain a membrane fraction
the level of GAPDH was detected, suggestwhich was resuspended in isotonic sucrose and loaded on top of an 18% Percoll solution.
ing that the process of chaperone-mediSelf-forming gradients were generated by centrifugation at 25,000 rpm in a SW55Ti rotor for
ated autophagy was not impaired in those
40 min at 4ºC. Seven fractions were collected from the top (low density) to the bottom (densest
fraction) and acid hydrolase content was determined by enzyme assays. Graphs represent the
cells. As in the exocrine glands, the level
distribution of α-galactosidase, β-hexosaminidase, and α-mannosidase in wild-type (n = 3) or
of phosphorylation of the mTOR target
Gnptab −/− (n = 3) liver and brain, expressed as a percentage of the total activity recovered in
p70S6K was elevated in the Gnptab −/− fieach fraction.
broblasts compared with wild-type levels,
indicating inhibition rather than activation
I-cell disease for inclusion-cell disease), we were surprised that we
of the macroautophagy pathway (Figure 8C). The cellular level of
did not detect morphological alterations in the fibrocytes and fiBeclin-1 was unchanged (Figure 8C).
broblasts examined during the histologic survey of the Gnptab −/−
These findings show that the Gnptab −/− fibroblasts accumouse tissues (Vogel et al., 2009). Subsequently, we became
mulate enlarged lysosomes and/or autolysosomes, most likely
aware of a 1975 publication by Aula et al. reporting that fibrosecondary to the severe depletion of acid hydrolases that impairs
blasts in tissues from a human mucolipidosis II fetus had detectthe degradative function of the lysosomes and autolysosomes. A
able inclusions when the samples were embedded in epoxy, but
similar decrease in acid hydrolase content was reported in fibronot in paraffin, the method used for our prior histologic analysis
blasts isolated from mucolipidosis type II patients and from a
1142 | M. Boonen et al.
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Gnptab knock-in mouse model of mucolipidosis type II (Kornfeld and Sly, 2000;
Kollmann et al., 2010). Moreover, Otomo
et al. recently showed that fibroblasts of patients with mucolipidosis II accumulate autolysosomes that can account for the inclusions initially observed by light microscopy
(Leroy and Demars, 1967; Otomo et al.,
2009).

DISCUSSION

Figure 7: Gnptab −/− mouse skin fibroblasts accumulate enlarged lysosomes and/or
autolysosomes. (A) Electron micrograph of a typical lysosome in wild-type mouse skin fibroblasts
immunogold labeled (10-nm gold particles) for cathepsin D. (B–D) Electron micrographs showing
the accumulation of enlarged lysosomes and/or autolysosomes (asterisks) in Gnptab −/− mouse
skin fibroblasts, recognized by their dense heterogeneous content, the occasional presence of
(D) mitochondrial remnants, and (C, D) the detection of LAMP-2 in their membrane. (B) The
enlarged lysosomes and autolysosomes contain low levels of cathepsin D. M, mitochondrion;
PM, plasma membrane; *, swollen lysosome or autolysosome.
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Figure 8: The level of LC3-II is elevated in Gnptab −/− mouse skin fibroblasts, while
stimulation of macroautophagy via the Beclin-1 or mTOR pathway is not detected.
(A, B) Immunoblots showing the increased levels of (A) LC3-II and LAMP-2 and (B) ubiquitinated
proteins in Gnptab −/− mouse skin fibroblasts over wild-type levels. (Two independent cell
lysates are shown for each genotype, indicated as +/+ and −/− for wild-type and Gnptab
−/− mice, respectively.) (C) Detection by Western blotting of Beclin-1, whose levels are
unchanged between +/+ and −/− cells, and of the mTOR target p70S6K, which is slightly more
phosphorylated in the −/− fibroblasts compared with wild-type cells. (A–C) The level of GAPDH
is similar in +/+ and −/− cells.
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We previously reported that acinar cells of
the exocrine glands of Gnptab −/− (MLII)
mice exhibit extensive vacuolization when
examined by light microscopy (Gelfman
et al., 2007; Vogel et al., 2009). These morphological abnormalities are similar to those
described in the exocrine pancreas, salivary
glands, and gastric chief cells of several MLII
patients (Elleder and Martin, 1998). On the
basis of our analysis of the acinar cells of the
salivary and pancreatic glands of Gnptab
−/− mice, we now demonstrate that the
vacuolization represents the accumulation
of autolysosomes in the mucous and serous
cells of these organs. Our data show that
these autolysosomes are defective in degradative capacity, accounting for their striking
accumulation. Yet the involved exocrine
glands retain substantial amounts of acid
hydrolases despite the loss of the Man-6-P
signal. This finding is in contrast to fibroblasts which have similar morphological alterations but extremely low levels of acid
hydrolases due to massive hypersecretion of
these enzymes.
These observations can be explained by
considering the unique role of the Man-6-P
sorting pathway in regulated secretory cells
compared with other cell types (i.e., the fibroblasts). In fibroblasts, the newly synthesized acid hydrolases are packaged at the
TGN into clathrin-coated carriers by a Man6-P–dependent mechanism and transported
to the lysosomes (Figure 9C). When the synthesis of the Man-6-P signal is defective, as
occurs in Gnptab −/− mice, the acid hydrolases are hypersecreted via the constitutive
secretory pathway, resulting in very low cellular levels of the hydrolases (Figure 9D)
(Lee et al., 2007). In the regulated secretory
cells (Figure 9A), a portion of the newly synthesized acid hydrolases are similarly packaged into clathrin-coated carriers at the
TGN and transported to lysosomes. However, studies of pancreatic beta-cells have
shown that the majority of the hydrolases
escape entry into the clathrin-coated carriers and instead enter immature secretory
granules (ISGs) that bud from the TGN
(Kuliawat and Arvan, 1994). During granule
maturation, the Man-6-P–containing acid
MLII mice accumulate autolysosomes

| 1143

and even greater packaging of the hydrolases into ISGs. Most important, once the
hydrolases enter the ISGs, they would not
be retrieved by the Man-6-P–dependent
system. This hypothesis is supported by the
observations of Kuliawat et al., who reported that the loss of one of the two MPRs
in mice, the cation-dependent MPR, resulted in a nearly fourfold increase in the
presence of the precursor form of cathepsin
B in the regulated secretory pathway of
pancreatic beta-cells (Kuliawat et al., 1997).
The lack of binding of acid hydrolases to
both of the MPRs in Gnptab −/− mice exocrine cells would be expected to impair the
sorting and retrieval of the acid hydrolases
to lysosomes even more. As a result, their
lysosomes would be deficient in acid hydrolases and unable to efficiently degrade material derived from the endocytic and autophagic pathways. The finding that the
cathepsin D content of the pancreatic acinar
cell lysosomes of Gnptab −/− mice is decreased to 37% of the wild-type levels
whereas the total cellular content of this
protease is normal or even increased is consistent with this model.
In addition, the modest decrease in the
intracellular levels of several other acid hydrolases suggests their increased secretion
by the Gnptab −/− acinar cells, either via
the constitutive secretory pathway and/or
as the result of secretory granule fusion with
the plasma membrane followed by release
Figure 9: Model for the consequences of the lack of the Man-6-P signal on the trafficking of
of their contents. It should be noted that the
acid hydrolases in fibroblasts and secretory cell types (salivary and pancreatic gland acinar cells).
extent of this secretion could be underesti(A) In secretory cell types, acid hydrolases can reach the lysosomes by two pathways: direct
mated in our assay. The steady-state level of
sorting from the TGN, or retrieval from the ISGs that had incorporated a portion of the newly
the acid hydrolases in the acinar cells is desynthesized hydrolases while budding off the TGN. Both processes involve packaging of the
termined by the rate of synthesis, the extent
hydrolases in CCVs by a Man-6-P–dependent mechanism. (B) In the absence of the Man-6-P
of secretion, and their half-life. Sardiello et
signal (Gnptab −/− cells), the hydrolases either undergo constitutive secretion or are trapped
al. reported that acid hydrolase synthesis is
within mature secretory granules due to the lack of retrieval from the ISGs. As a result,
lysosomes (L) have low levels of acid hydrolases. The accumulation of autolysosomes (AL) in the
up-regulated in fibroblasts from patients
salivary glands and pancreas of the Gnptab −/− mice is the consequence of the resulting
with several forms of lysosomal storage disdefective lysosomal degradative capacity. (C) In normal fibroblasts, acid hydrolases are
eases (Sardiello et al., 2009). If acid hydropackaged into clathrin-coated transport carriers at the TGN and targeted to lysosomes (L) in a
lase synthesis is increased in the acinar cells
Man-6-P–dependent manner. (D) The loss of the Man-6-P signal in Gnptab −/− fibroblasts, and
of the Gnptab −/− mice, this could help
the subsequent lack of recognition of the hydrolases at the TGN, results in their hypersecretion
maintain the intracellular levels of some acid
via the constitutive secretory pathway. Consequently, lysosomes (L) and autolysosomes (AL) with
hydrolases in the face of significant hyperselow acid hydrolase content and poor degradative capacity accumulate.
cretion of these enzymes. Nevertheless the
issue of entrapment in secretory granules
hydrolases are then removed by a mechanism involving binding to
would remain. Finally, because we only assayed for a limited numMan-6-P receptors (MPRs) and incorporation into AP-1 and syntaxinber of acid hydrolases, we cannot exclude the possibility, although
6-positive clathrin-coated vesicles (CCVs) that bud from the ISGs
unlikely, that one particular acid hydrolase (out of the total 60 enand transport their cargo to endolysosomes (Tooze and Tooze,
zymes that reside in lysosomes) might be dramatically reduced in
1986; Kuliawat et al., 1997; Klumperman et al., 1998; Dittié et al.,
the lysosomes, leading to the impaired degradative capacity of
1999). This process provides an “exit site” for acid hydrolases that
these compartments.
enter the regulated secretory pathway, allowing retrieval to lysoUnfortunately we were unable to formally demonstrate the missomes. The inability to synthesize the Man-6-P marker in the Gnptab
sorting of the acid hydrolases into mature secretory granules of the
−/− mice would have several consequences in these cells (Figure 9B).
mutant cells. By immuno-EM using cathepsin D antibodies, we only
At the TGN, the newly synthesized acid hydrolases would be poorly
observed background labeling of the secretory granules of wildsorted into CCVs due to their inability to bind MPRs, which would
type and mutant pancreatic acinar cells. In addition, homogenizaresult in increased secretion via the constitutive secretory pathway
tion and subcellular fractionation of the Gnptab −/− pancreas
1144 | M. Boonen et al.
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resulted in extensive autolysosome disruption, which made it impossible to determine whether the secretory granules in the mutant
pancreas contained increased amounts of acid hydrolases. Meister
et al. recently reported this same problem with pancreatic tissue of
cation-independent MPR–deficient mice (Meister et al., 2010). Similar to our work, these authors described the formation of large cytoplasmic vacuoles in the pancreas of those mice, although much less
severe than in the Gnptab −/− mice (Gelfman et al., 2007).
We did not detect convincing evidence for macroautophagy activation in the exocrine glands of the Gnptab −/− mice (3–4-mo-old
mice), based on evaluation of Beclin-1 levels and activity of mTOR.
However, we cannot rule out the possibility that stimulation of macroautophagy may have contributed to pathological development at
an earlier stage of the process. In addition, the numerous profiles of
ongoing crinophagy and microautophagy observed in the mutant
salivary glands raise the possibility that these processes may be
stimulated, perhaps representing an attempt to dispose of secretory granules that have been damaged by their content of acid hydrolases. This activation could contribute to the accumulation of
autolysosomes. In the Gnptab −/− pancreas, the accumulation of
autolysosomes was accompanied by a decrease in the number of
lysosomes. These data are consistent with the recent report that
inhibition of autolysosomal protein degradation with protease inhibitors abrogates lysosome reformation, leading to the accumulation of enlarged and long-lived autolysosomes (Yu et al., 2010). The
accumulation of autolysosomes in our MLII mouse also points out
an important difference compared with other lysosomal storage
disorders with autophagy defects, including multiple sulfatase deficiency and mucopolysaccharidosis IIIA. Studies of mouse models of
these disorders revealed that the affected cells exhibit an accumulation of autophagosomes, rather than autolysosomes, resulting from
a defect in the fusion of the autophagosomes with lysosomes
(Settembre et al., 2008; Fraldi et al., 2010). By contrast, the defect
in the Gnptab −/− mice appears to be the failure to dispose of the
engulfed material by lysosomes and autolysosomes deficient for
critical lysosomal hydrolases.
Our data support previous reports that the requirement for the
Man-6-P–dependent sorting pathway varies substantially among
cell types. At one extreme, fibroblasts (cells of mesenchymal origin)
are highly dependent on the Man-6-P pathway for efficient acid hydrolase sorting and lysosomal function. Our findings now demonstrate that the lysosomal function of the exocrine secretory cells is
also highly dependent on the Man-6-P pathway. It is of note that
exocrine secretory cells and organs, including the pancreas, appear
to have a relatively high basal level of autophagy compared with
other tissues (Mizushima et al., 2004). This might explain why the
autolysosomes detected in the exocrine cells of the Gnptab −/−
mice were generally more prevalent than observed in fibroblasts
and often filled with easily recognizable remnants of material derived from macro-, micro-, or crinophagy. At the other extreme, the
liver, brain, and muscle of the Gnptab −/− mice have normal or even
elevated levels of acid hydrolases that are correctly localized within
lysosomes, despite the loss of the Man-6-P signal, and do not exhibit any obvious morphological alterations. These findings are in
agreement with those previously reported for postmortem samples
obtained from patients with MLII (Kenyon et al., 1973; Martin et al.,
1975, 1984; Nagashima et al., 1977; Owada and Neufeld, 1982;
Waheed et al., 1982). The liver, which is known to have a high endocytosis capacity, had an increased level of all the measured acid hydrolases, which could reflect their capture from the plasma where
the levels are extremely elevated in the mutant mice (Gelfman et al.,
2007). However, while endocytosis might contribute to the normal
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or elevated levels of acid hydrolases in the brain and muscle, a more
likely explanation is that these tissues utilize an intracellular Man-6P–independent targeting pathway(s). This is consistent with previous studies demonstrating the existence of a Man-6-P–independent
intracellular sorting pathway for cathepsin D in MLII lymphoblasts
and thymocytes isolated from mice deficient in both Man-6-P receptors (Glickman and Kornfeld, 1993; Glickman et al., 1996; Dittmer
et al., 1999). A major goal of future work will be to identify the molecular basis of the Man-6-P–independent pathway(s).

MATERIALS AND METHODS
Materials
Chemicals, including fluorogenic substrates for acid hydrolase enzyme assays, were obtained from Sigma Aldrich (St. Louis, MO)
unless otherwise specified. Mouse anti-ubiquitin antibody and
rabbit anti–Beclin-1, p70S6K, and phospho-p70S6K (Thr389) antibodies were purchased from Cell Signaling Technology (Danvers,
MA). Rabbit anti-LC3 and mouse anti-GAPDH antibodies were obtained from Novus Biologicals (Littleton, CO) and Sigma Aldrich,
respectively, and both rat anti–LAMP-1 and rat anti–LAMP-2
antibodies from Developmental Studies Hybridoma Bank (Iowa
City, IA). Goat anti-amylase antibody was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA) and rabbit anti-amylase
(AMY2B) from Proteintech Europe (Manchester, UK). The rabbit
anti–cathepsin D used for Western blots was produced in our laboratory. Cathepsin D was detected in immuno-EM with a rabbit
anti–cathepsin D antibody that was a generous gift from M. Koike
(Juntendo University Graduate School of Medicine, Tokyo,
Japan). Horseradish peroxidase (HRP)–coupled secondary antibodies were purchased from GE Healthcare (Piscataway, NJ). For
immuno-EM, rabbit anti–rat immunoglobulin (Ig)G polyclonal antibody (DAKO, Heverlee, Belgium) was used as a bridging step
between rat monoclonal antibody (mAb) and protein A-gold (Cell
Microscopy Center, UMC Utrecht, the Netherlands). Cellgro AlphaMinimum Essential Media and penicillin/streptomycin were obtained from Fisher Scientific (Pittsburgh, PA) and fetal calf serum
(FCS) from ISC BioExpress (Kaysville, UT). The Gnptab −/− mice
were described previously (Gelfman et al., 2007).

Enzyme assays
Mouse skin fibroblasts were isolated from wild-type and
Gnptab −/− mouse ears and maintained in α-MEM medium containing 20% FCS, 100 μg/ml penicillin, and 100 U/ml streptomycin.
Organs were collected from 3–4-mo-old mice after perfusion
through the heart with phosphate-buffered saline (PBS) (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.5).
Tissues or confluent cells in culture were suspended in PBS containing 1% Triton X-100 and a mixture of protease inhibitors (complete
mini protease inhibitor tablets; Roche, Penzberg, Germany) for
15 min on ice and then sonicated and centrifuged for 15 min at
13,000 g. Lysosomal hydrolase activities were determined in the
supernatants by fluorometric enzyme assays as described (Lee
et al., 2007). Briefly, the samples were incubated with either 1 mM
(tissue samples) or 5 mM (cultured fibroblasts lysates) of 4-methylumbelliferyl–coupled specific substrates in a 50-mM citrate buffer
containing 0.5% Triton X-100 (pH 4.5) at 37ºC, except for the
β-glucocerebrosidase assay that was performed in a buffer containing 0.1 M sodium citrate, 0.2 M Na2HPO4, 0.2% TX-100, and 0.25%
sodium taurocholate, pH 5.2. Reactions were stopped by addition
of 0.1 M glycine-NaOH solution (pH 10.3) and the fluorescence was
read at 495 nm. Activities were expressed as nanomoles of hydrolyzed methylumbelliferone per milligram protein and per hour.
MLII mice accumulate autolysosomes
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Percoll density gradients
Wild-type and Gnptab −/− mice that were 2–3 mo of age were
anesthetized and subsequently perfused with PBS to remove blood
from their organs. The brains and livers of these mice were removed
and fractionated on an 18% self-forming Percoll density gradient as
described previously (Boonen et al., 2009). Briefly, a membrane fraction was prepared, loaded on top of an 18% Percoll solution (18%
[vol/vol] Percoll [Pharmacia, Uppsala, Sweden], 0.25 M sucrose,
2 mM EDTA, and 10 mM Tris/HCl [pH 7.4]) and centrifuged at
25,000 rpm in a Beckman SW55Ti rotor for 40 min at 4ºC. Seven
fractions were collected from the top of the gradient. The distribution of three different lysosomal hydrolases was determined by enzyme assays as described earlier.

Western blotting
Identical amounts of wild-type or Gnptab −/− protein samples (lysed in PBS containing 1% Triton X-100 and protease inhibitors as
described earlier) were resolved on polyacrylamide gels and
transferred onto polyvinylidene fluoride membranes (Millipore,
Billerica, MA), which then were blocked in 10% fat-free milk in
PBS/Tween 0.1% for 30 min at room temperature (RT) prior to incubation overnight at 4ºC with primary antibodies diluted in PBS/
Tween 0.1% containing 0.2% fat-free milk. After washing with PBS/
Tween 0.1%, blots were incubated for 45 min at RT with HRP-coupled secondary antibodies diluted in PBS/Tween 0.1% containing
0.2% fat-free milk and washed. Immunoreactive bands were revealed by chemiluminescence (ECL Amersham, Piscataway, NJ).

EM
Wild-type and Gnptab −/− mice at 1.5–2 mo of age were sedated
and perfused via the heart with either 2% wt/vol paraformaldehyde
(PFA) in 0.1 M phosphate buffer (PB) pH 7.4 or 2% wt/vol PFA, 0.2%
wt/vol glutaraldehyde (GA, from Polysciences Europe GmbH,
Eppelheim, Germany) in 0.1 M PB, pH 7.4. Following the perfusion
fixation with 2% PFA, the tissues were removed and immediately
immersed in 4% wt/vol PFA in 0.1 M PB and kept overnight at 4°C.
In case of the perfusion fixation with 2% PFA, 0.2% GA, the tissues
of interest were divided into two halves and either immersed in the
same fixative, kept overnight at 4°C, and processed for cryosectioning or immersed in 2% wt/vol PFA, 2.5% wt/vol GA in Na-cacodylate
buffer (Karnovsky fixative) for 2 h at RT. Subsequently, the Karnovsky
fixative was replaced for 0.1 M Na-cacodylate buffer, pH 7.4. Prior
to Epon embedding, the tissues were postfixed with 1% wt/vol
OsO4, 1.5% wt/vol K3Fe(III)(CN)6 in 0.065 M Na-cacodylate for 2 h
at 4°C. Subsequently the tissues were stained with 0.5% uranyl acetate for 1 h at 4°C, dehydrated with ethanol, and embedded in
Epon. Ultrathin sections were stained with uranyl acetate and lead
citrate.
For cryosectioning and immuno-EM, the fixed tissues were further processed as described (Slot and Geuze, 2007). In short, the
tissues were cut into small blocks, rinsed with PBS and PBS containing 0.02 M glycine, and embedded in 12% gelatin. The blocks were
incubated overnight in 2.3 M sucrose at 4°C, mounted on metal
pins, and frozen in liquid nitrogen. Ultrathin cryosectioning was performed at −120°C in a Leica UCT-FCS ultracryomicrotome (Leica
Microsystems, Vienna, Austria). The sections were transferred to
copper grids by pickup with a 1:1 mixture of 2.3 M sucrose in PBS
and 2% wt/vol methyl cellulose. For immunogold labeling, the grids
were incubated first on 2% gelatin/PBS at 37°C, blocked with
0.02 M glycine/PBS and 1% bovine serum albumin/PBS, and subsequently incubated with primary antibodies followed by protein
A-gold. The sections were contrasted with 2% uranyl acetate/ox1146 | M. Boonen et al.

alate, pH 7, followed by 0.4% uranyl acetate pH 4 and 1.8% methyl
cellulose (Slot and Geuze, 2007).
Mouse skin fibroblasts were fixed by addition of an equal volume
of 4% wt/vol PFA in 0.1 M PB to the culture medium. After ∼10 min,
the fixative was replaced for 4% wt/vol PFA in 0.1 M PB for at least
2 h at RT and the cells were processed for cryosectioning and immunogold labeling.
All sections were analyzed in a JEOL 1200 EX (Tokyo, Japan)
electron microscope at 60 or 80 kV for Epon or cryosections, respectively. Quantification of the number of autophagosomes, autolysosomes, and lysosomes was performed in ultrathin cryosections of
wild-type and Gnptab −/− pancreas labeled for LAMP-2. Values are
average numbers per cell profile ± SE of the mean. Autophagosomes were defined as compartments containing cytoplasmic material but that were devoid of LAMP-2 labeling. Autolysosomes were
distinguished by the presence of undegraded cytoplasmic material
and the presence of LAMP-2 on their limiting membrane, whereas
lysosomes were defined as LAMP-2–positive compartments with
homogeneous content that occasionally contained visible internal
membrane sheets. In total, 15 cell profiles from two grids of wildtype or Gnptab −/− pancreatic acinar cells were assessed for the
presence of lysosomes and autolysosomes and 30 cell profiles
for the presence of autophagosomes. Quantification of the cathepsin D labeling in late endosomes and lysosomes of wild-type and
Gnptab −/− pancreatic acinar cells was performed by random
screening of LAMP-1 and cathepsin D double-labeled sections. Late
endosomes and lysosomes were defined as LAMP-1–positive compartments with a diameter size >200 nm that were devoid of undegraded autophagic material. The number of gold particles representing cathepsin D was scored per compartment. In total, 29
endolysosomal compartments were assessed in both wild-type and
Gnptab −/− cells, out of which the average cathepsin D labeling
level was determined; ± values are standard deviations. The surface
of the late endosomes and lysosomes was measured with a square
lattice overlaying the electron micrographs by counting the number
of points within the compartment (point hit method, Griffiths, 1993).
The mesh size of the square lattice was adjusted to the magnification of the electron micrographs: 7.5, 10.28, and 12.45 mm for magnifications of 30,000×, 40,000×, and 49,000×, respectively. The
labeling density of cathepsin D was calculated by dividing the number of gold particles for cathepsin D by the product of the number
of points and the area associated with one point (0.0088 μm2). In this
way the numerical density of gold over an area was obtained in gold
particles per μm2 (Griffiths, 1993). The size of the secretory granules
in wild-type and Gnptab −/− pancreatic acinar cells was determined
by using the same point hit method. In total, 165 and 211 secretory
granules were evaluated in the wild-type and Gnptab −/−, respectively. P values were determined by performing a t test.
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